Clinical Trials Browser

Phase 4 × Delirium × Clear all

NCT05834569 2025-09-05

Impact of Maxigesic on Delirium After Minimally Invasive Lung Surgery in Elderly Patients

Phase 4 Terminated

Emergence Delirium, Delirium, Lung Neoplasms

NCT04532606 2025-07-30

Impact of Remimazolam on Prognosis After Bladder Cancer Surgery

Phase 4 Recruiting

Emergence Delirium, Urinary Bladder Neoplasms, Delirium

NCT06834386 2025-05-01

Suvorexant for Insomnia to Prevent Delirium in Hospitalized Cancer Patients

Phase 4 Withdrawn

Delirium, Sleep Initiation and Maintenance Disorders

NCT03200600 2021-07-13

Dexamethasone, Flurbiprofen Axetil and Delirium After Lung Cancer Surgery

Phase 4 Terminated

Carcinoma, Non-Small-Cell Lung, Delirium

NCT04399343 2021-01-28

DEPOD

Phase 4 Unknown

Central Nervous System Diseases, Delirium

NCT04494828 2021-01-12

Impact Dexmedetomidine on Postoperative Delirium in Patients After Intracranial Operation for Brain Tumor

Phase 4 Completed

Central Nervous System Diseases, Delirium

NCT03489551 2018-05-22

PHDC

Phase 4 Completed

17 enrolled 5 charts

Delirium